vs
GLOBUS MEDICAL INC（GMED）与越洋钻探（RIG）财务数据对比。点击上方公司名可切换其他公司
越洋钻探的季度营收约是GLOBUS MEDICAL INC的1.3倍（$1.0B vs $826.4M），GLOBUS MEDICAL INC净利率更高（17.0% vs 2.4%，领先14.6%），GLOBUS MEDICAL INC同比增速更快（25.7% vs 9.6%），越洋钻探自由现金流更多（$321.0M vs $202.4M），过去两年越洋钻探的营收复合增速更高（16.9% vs 16.7%）
Globus Medical是总部位于美国宾夕法尼亚州奥杜邦的上市骨科医疗器械企业，专注于相关产品的设计、研发与商业化，助力外科医生为肌肉骨骼系统疾病患者提供治疗方案，促进患者康复。
越洋钻探（Transocean Ltd.）是按营收计全球规模最大的海上钻探承包商，总部位于瑞士施泰因豪森，起源于美国，目前在加拿大、美国、挪威、英国、印度、巴西、新加坡等20个国家设有办事机构，业务覆盖全球主要海上油气开采区域。
GMED vs RIG — 直观对比
营收规模更大
RIG
是对方的1.3倍
$826.4M
营收增速更快
GMED
高出16.2%
9.6%
净利率更高
GMED
高出14.6%
2.4%
自由现金流更多
RIG
多$118.6M
$202.4M
两年增速更快
RIG
近两年复合增速
16.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $826.4M | $1.0B |
| 净利润 | $140.6M | $25.0M |
| 毛利率 | 68.4% | 42.0% |
| 营业利润率 | 20.5% | 23.0% |
| 净利率 | 17.0% | 2.4% |
| 营收同比 | 25.7% | 9.6% |
| 净利润同比 | 430.4% | 257.1% |
| 每股收益（稀释后） | $1.01 | $0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GMEDRIG
| Q4 25 | $826.4M | $1.0B | ||
| Q3 25 | $769.0M | $1.0B | ||
| Q2 25 | $745.3M | $988.0M | ||
| Q1 25 | $598.1M | $906.0M | ||
| Q4 24 | $657.3M | $952.0M | ||
| Q3 24 | $625.7M | $948.0M | ||
| Q2 24 | $629.7M | $861.0M | ||
| Q1 24 | $606.7M | $763.0M |
净利润GMEDRIG
| Q4 25 | $140.6M | $25.0M | ||
| Q3 25 | $119.0M | $-1.9B | ||
| Q2 25 | $202.8M | $-938.0M | ||
| Q1 25 | $75.5M | $-79.0M | ||
| Q4 24 | $26.5M | $7.0M | ||
| Q3 24 | $51.8M | $-494.0M | ||
| Q2 24 | $31.8M | $-123.0M | ||
| Q1 24 | $-7.1M | $98.0M |
毛利率GMEDRIG
| Q4 25 | 68.4% | 42.0% | ||
| Q3 25 | 67.2% | 43.2% | ||
| Q2 25 | 66.6% | 39.4% | ||
| Q1 25 | 67.3% | 31.8% | ||
| Q4 24 | 59.9% | 39.2% | ||
| Q3 24 | 56.8% | 40.6% | ||
| Q2 24 | 58.7% | 38.0% | ||
| Q1 24 | 60.2% | 31.5% |
营业利润率GMEDRIG
| Q4 25 | 20.5% | 23.0% | ||
| Q3 25 | 17.9% | -163.1% | ||
| Q2 25 | 10.2% | -97.6% | ||
| Q1 25 | 16.2% | 7.1% | ||
| Q4 24 | 9.2% | 13.7% | ||
| Q3 24 | 7.7% | -51.2% | ||
| Q2 24 | 7.9% | -6.9% | ||
| Q1 24 | 1.3% | -0.4% |
净利率GMEDRIG
| Q4 25 | 17.0% | 2.4% | ||
| Q3 25 | 15.5% | -187.1% | ||
| Q2 25 | 27.2% | -94.9% | ||
| Q1 25 | 12.6% | -8.7% | ||
| Q4 24 | 4.0% | 0.7% | ||
| Q3 24 | 8.3% | -52.1% | ||
| Q2 24 | 5.0% | -14.3% | ||
| Q1 24 | -1.2% | 12.8% |
每股收益（稀释后）GMEDRIG
| Q4 25 | $1.01 | $0.13 | ||
| Q3 25 | $0.88 | $-2.00 | ||
| Q2 25 | $1.49 | $-1.06 | ||
| Q1 25 | $0.54 | $-0.11 | ||
| Q4 24 | $0.19 | $-0.14 | ||
| Q3 24 | $0.38 | $-0.58 | ||
| Q2 24 | $0.23 | $-0.15 | ||
| Q1 24 | $-0.05 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $557.2M | $620.0M |
| 总债务越低越好 | — | $5.2B |
| 股东权益账面价值 | $4.6B | $8.1B |
| 总资产 | $5.3B | $15.6B |
| 负债/权益比越低杠杆越低 | — | 0.64× |
8季度趋势，按日历期对齐
现金及短期投资GMEDRIG
| Q4 25 | $557.2M | $620.0M | ||
| Q3 25 | $18.8M | $833.0M | ||
| Q2 25 | — | $377.0M | ||
| Q1 25 | — | $263.0M | ||
| Q4 24 | $890.1M | $560.0M | ||
| Q3 24 | $71.9M | $435.0M | ||
| Q2 24 | $82.5M | $475.0M | ||
| Q1 24 | $80.4M | $446.0M |
总债务GMEDRIG
| Q4 25 | — | $5.2B | ||
| Q3 25 | — | $4.8B | ||
| Q2 25 | — | $5.9B | ||
| Q1 25 | — | $5.9B | ||
| Q4 24 | — | $6.2B | ||
| Q3 24 | — | $6.5B | ||
| Q2 24 | — | $6.8B | ||
| Q1 24 | — | $6.8B |
股东权益GMEDRIG
| Q4 25 | $4.6B | $8.1B | ||
| Q3 25 | $4.4B | $8.1B | ||
| Q2 25 | $4.3B | $9.4B | ||
| Q1 25 | $4.1B | $10.2B | ||
| Q4 24 | $4.2B | $10.3B | ||
| Q3 24 | $4.1B | $10.2B | ||
| Q2 24 | $4.0B | $10.7B | ||
| Q1 24 | $3.9B | $10.5B |
总资产GMEDRIG
| Q4 25 | $5.3B | $15.6B | ||
| Q3 25 | $5.1B | $16.2B | ||
| Q2 25 | $5.0B | $17.8B | ||
| Q1 25 | $4.7B | $19.0B | ||
| Q4 24 | $5.3B | $19.4B | ||
| Q3 24 | $5.1B | $19.5B | ||
| Q2 24 | $5.0B | $20.3B | ||
| Q1 24 | $4.9B | $19.9B |
负债/权益比GMEDRIG
| Q4 25 | — | 0.64× | ||
| Q3 25 | — | 0.60× | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.63× | ||
| Q1 24 | — | 0.65× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $248.6M | $349.0M |
| 自由现金流经营现金流 - 资本支出 | $202.4M | $321.0M |
| 自由现金流率自由现金流/营收 | 24.5% | 30.8% |
| 资本支出强度资本支出/营收 | 5.6% | 2.7% |
| 现金转化率经营现金流/净利润 | 1.77× | 13.96× |
| 过去12个月自由现金流最近4个季度 | $588.8M | $626.0M |
8季度趋势，按日历期对齐
经营现金流GMEDRIG
| Q4 25 | $248.6M | $349.0M | ||
| Q3 25 | $249.7M | $246.0M | ||
| Q2 25 | $77.9M | $128.0M | ||
| Q1 25 | $177.3M | $26.0M | ||
| Q4 24 | $210.3M | $206.0M | ||
| Q3 24 | $203.7M | $194.0M | ||
| Q2 24 | $54.3M | $133.0M | ||
| Q1 24 | $52.4M | $-86.0M |
自由现金流GMEDRIG
| Q4 25 | $202.4M | $321.0M | ||
| Q3 25 | $213.9M | $235.0M | ||
| Q2 25 | $31.3M | $104.0M | ||
| Q1 25 | $141.2M | $-34.0M | ||
| Q4 24 | $193.2M | $177.0M | ||
| Q3 24 | $161.7M | $136.0M | ||
| Q2 24 | $26.5M | $49.0M | ||
| Q1 24 | $23.8M | $-169.0M |
自由现金流率GMEDRIG
| Q4 25 | 24.5% | 30.8% | ||
| Q3 25 | 27.8% | 22.9% | ||
| Q2 25 | 4.2% | 10.5% | ||
| Q1 25 | 23.6% | -3.8% | ||
| Q4 24 | 29.4% | 18.6% | ||
| Q3 24 | 25.8% | 14.3% | ||
| Q2 24 | 4.2% | 5.7% | ||
| Q1 24 | 3.9% | -22.1% |
资本支出强度GMEDRIG
| Q4 25 | 5.6% | 2.7% | ||
| Q3 25 | 4.7% | 1.1% | ||
| Q2 25 | 6.2% | 2.4% | ||
| Q1 25 | 6.0% | 6.6% | ||
| Q4 24 | 2.6% | 3.0% | ||
| Q3 24 | 6.7% | 6.1% | ||
| Q2 24 | 4.4% | 9.8% | ||
| Q1 24 | 4.7% | 10.9% |
现金转化率GMEDRIG
| Q4 25 | 1.77× | 13.96× | ||
| Q3 25 | 2.10× | — | ||
| Q2 25 | 0.38× | — | ||
| Q1 25 | 2.35× | — | ||
| Q4 24 | 7.94× | 29.43× | ||
| Q3 24 | 3.93× | — | ||
| Q2 24 | 1.71× | — | ||
| Q1 24 | — | -0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GMED
| Other | $391.8M | 47% |
| Nevro Merger Agreement | $293.6M | 36% |
| Enabling Technologies | $141.0M | 17% |
RIG
| Ultra Deepwater Floaters | $433.0M | 42% |
| BR | $236.0M | 23% |
| Other Geographical | $211.0M | 20% |
| Harsh Environment Floaters | $163.0M | 16% |
